ライブ
CellA skin-hypothalamus axis couples heat stress and metabolic dysfunctionCellThe evolution of high-order genome architecture revealed from 1,000 speciesCellSomatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative statesCellPyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylationCellMechanism-guided identification of antidepressant G protein-coupled receptor drug targetsBDArea Softball: PRB gets 2 wins - Brainerd DispatchFierceBiotechWCG acquires The Contract Network in bid to streamline clinical trial executionRecursionRecursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com CanadaRecursionRecursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock TitanRecursion[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
Endpoints News 2025年11月26日

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

原文
本文は利用できません。元の情報源をご確認ください。